Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/14/2012WO2012076985A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012WO2012076977A1 Method of extracting active molecules from natural resins and use thereof
06/14/2012WO2012076974A1 8-triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists
06/14/2012WO2012076966A1 Substituted thieno [3,4-b] pyrazine compounds
06/14/2012WO2012076961A2 New carnosine compound
06/14/2012WO2012076942A1 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
06/14/2012WO2012076934A1 Glycomimetic compounds as anti-infectious against pathogens lectins
06/14/2012WO2012076919A1 Process of preparing ebastine
06/14/2012WO2012076916A1 Therapeutic association of 5 - hydroxy - tryptophan and caffeine for the treatment of the symptom of parkinson's disease, daytime sleepiness
06/14/2012WO2012076898A1 Triazole derivatives as wnt signaling pathway inhibitors
06/14/2012WO2012076897A1 Disulfiram formulation and uses thereof
06/14/2012WO2012076877A1 Hydantoin derivatives useful as kv3 inhibitors
06/14/2012WO2012076842A1 Synthetic retinoids for control of cell differentiation
06/14/2012WO2012076832A1 Suppositories comprising rifaximin
06/14/2012WO2012076831A1 [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
06/14/2012WO2012076824A1 Novel derivatives of oxazaphosphorines that are pre-activated, use and method of preparation
06/14/2012WO2012076756A2 New pharmaceutical compositions
06/14/2012WO2012076736A1 Deuterated phenacyl and derivatives, method for the preparation thereof and uses thereof
06/14/2012WO2012076735A1 Deuterated 5-trideuteromethyl-6-methyl-2-thioxo-2,3-dihydropyridin -4(1h)-one compounds and method for the preparation thereof
06/14/2012WO2012076718A1 Anti-microbial composition
06/14/2012WO2012076717A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012WO2012076691A1 New form of administration of enkephalinase inhibitor
06/14/2012WO2012076688A1 Combination comprising a derivative of the family of the combretastatins and cetuximab
06/14/2012WO2012076685A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
06/14/2012WO2012076684A1 Dosages of arylsulfonamide derivatives
06/14/2012WO2012076680A1 Combination preparation for improving female fertility
06/14/2012WO2012076679A1 Use of dronedarone for the preparation of a drug for use in the management of the risk of liver injury
06/14/2012WO2012076674A1 Imidazo(4,5-b)pyridine-6-carboxamides as anti-inflammatory agents
06/14/2012WO2012076673A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012WO2012076672A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
06/14/2012WO2012076667A1 Compounds for treatment of heart failure
06/14/2012WO2012076639A1 Carboxamide compounds and their use as calpain inhibitors v
06/14/2012WO2012076590A1 Novel triazole compounds iii
06/14/2012WO2012076555A1 Autophagy enhancing compounds, peptides and peptidomimetic compounds for use in the treatment of neuronal diseases
06/14/2012WO2012076516A1 Pharmaceutical composition comprising dutasteride
06/14/2012WO2012076513A1 3-cyano-1-hydroxymethyl-2-phenylpyrrolidine derivatives as inhibitors of mdm2-p53 interactions useful for the treatment of cancer
06/14/2012WO2012076443A1 Liposomal formulation of dalcetrapib
06/14/2012WO2012076430A1 Triazolopyridine compounds
06/14/2012WO2012076429A1 Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
06/14/2012WO2012076413A1 Compound for the treatment of tumours and tumour metastases
06/14/2012WO2012076352A1 Composition for topical use for treating skin disorders
06/14/2012WO2012076323A1 Oligosaccharide composition for treating acute respiratory tract infections
06/14/2012WO2012076322A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/14/2012WO2012076321A1 Oligosaccharide composition for treating skin diseases
06/14/2012WO2012076194A1 Combination preparations comprising a cytokine antagonist and corticosteroid
06/14/2012WO2012076193A1 Combination preparations comprising exosomes and corticosteroid
06/14/2012WO2012076190A1 Bispecific aptamers mediating tumour cell lysis
06/14/2012WO2012076063A1 Pyridine amide derivatives as ep4 receptor antagonists
06/14/2012WO2012076016A1 Process for the manufacture of ajoene derivatives
06/14/2012WO2012075957A1 Use of phenethyl caffeate derivatives in the preparation of a medicament against tumor angiogenesis
06/14/2012WO2012075927A1 Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
06/14/2012WO2012075917A1 Compounds
06/14/2012WO2012075908A1 Use of quinazoline compound in preparation of anti-flavivirus drug
06/14/2012WO2012075849A1 4',5-dihydroxy-7-[4-(n, n-diethylamino) butoxy] isoflavones, and preparation method and application thereof
06/14/2012WO2012075754A1 Pharmaceutical composition for treating acute lymphocytic leukemia
06/14/2012WO2012075744A1 Pharmaceutical composition comprising pyrazolopyrimidinone-like compound
06/14/2012WO2012075683A1 [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
06/14/2012WO2012075679A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
06/14/2012WO2012075678A1 Substituted thiazolyl pyrazolo pyridine compound and medicinal use thereof
06/14/2012WO2012075606A1 New pharmaceutic use of benzoic aicd derivatives
06/14/2012WO2012075584A1 Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d
06/14/2012WO2012059935A9 Process for preparing bendamus tine hydrochloride monohydrate
06/14/2012WO2012058128A3 Caprolactam mglur5 receptor modulators
06/14/2012WO2012056478A8 Oxazoline and isoxazoline derivatives as crac modulators
06/14/2012WO2012054816A3 Methods of delaying and treating diabetes
06/14/2012WO2012053758A3 Pharmaceutical composition for treating or preventing alcoholic liver diseases, containing cilostazol as active ingredient
06/14/2012WO2012053741A3 Nucleic acid molecules inducing rna interference, and uses thereof
06/14/2012WO2012052478A3 Topical gel composition
06/14/2012WO2012051988A3 Derivatives of steroid benzylamines, having an antiparasitic, antibacterial, antimycotic and/or antiviral action
06/14/2012WO2012051571A3 Nucleic acid modulators of clec-2
06/14/2012WO2012051117A3 Substituted benzamides and their uses
06/14/2012WO2012050971A3 Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use
06/14/2012WO2012050831A3 Combination treatment for dermatological conditions
06/14/2012WO2012050484A3 5-amino-1,2,4-thiadiazole derivatives
06/14/2012WO2012048265A3 Methods of treating inflammation
06/14/2012WO2012048013A3 Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections
06/14/2012WO2012047706A9 Methods for promotiing reinnervation of auditory hair cells
06/14/2012WO2012047656A8 Lipid a analog compositions
06/14/2012WO2012046945A3 Pharmaceutical and food composition for preventing or treating diabetes or obesity
06/14/2012WO2012044817A3 Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
06/14/2012WO2012040511A3 Compounds that modulate intracellular calcium
06/14/2012WO2012034116A3 Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
06/14/2012WO2012031123A3 Method of treating ear infections
06/14/2012WO2012030050A9 Pharmaceutical composition for prevention or treatment of degenerative neurological brain disorders
06/14/2012WO2012027731A3 Pharmaceutical composition and administrations thereof
06/14/2012WO2012027603A3 Therapeutic consumable compositions for reduction of facial flush effect incident to alcohol consumption in persons with deficient activity of the aldehyde dehydrogenase gene-aldh2
06/14/2012WO2012024293A3 Medical foods for the treatment of developmentally-based neuropsychiatric disorders via modulation of brain glycine and glutathione pathways
06/14/2012WO2012021891A3 Compositions, kits and methods for treatment of complement-related disorders
06/14/2012WO2012019188A3 Methods and compositions for the inhibition of fructokinase
06/14/2012WO2012012676A3 Use of mir-29 for cell protection
06/14/2012WO2012007948A3 CYTOTOXIC Ti (IV) COMPOUNDS
06/14/2012WO2012006563A3 Novel daidzein analogs as treatment for cancer
06/14/2012WO2011107944A3 Modified release dosage form
06/14/2012WO2011085278A3 Topical scar treatment composition
06/14/2012WO2011072241A9 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters
06/14/2012WO2011044185A3 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
06/14/2012WO2011042765A8 Inorganic salt complexes of vildagliptin
06/14/2012WO2010150144A3 Low dose pharmaceutical compositions of celecoxib
06/14/2012US20120151612 Non-surgical approach to prevent and correct craniofacial malformations during development
06/14/2012US20120150131 Polymer for Controlling Delivery of Bioactive Agents and Method of Use
1 ... 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 ... 7860